Carvacrol acts as a potent selective antagonist of different types of nicotinic acetylcholine receptors and enhances the effect of monepantel in the parasitic nematode Ascaris suum.
Aminoacetonitrile
/ analogs & derivatives
Animals
Antinematodal Agents
/ pharmacology
Ascaris suum
/ drug effects
Central Nervous System
/ drug effects
Cymenes
/ pharmacology
Diaphragm
/ drug effects
Female
Muscles
/ drug effects
Nicotinic Agonists
/ pharmacology
Nicotinic Antagonists
/ pharmacology
Rats
A. suum
Carvacrol
Monepantel
nAChR
Journal
Veterinary parasitology
ISSN: 1873-2550
Titre abrégé: Vet Parasitol
Pays: Netherlands
ID NLM: 7602745
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
09
09
2019
revised:
15
01
2020
accepted:
16
01
2020
pubmed:
8
2
2020
medline:
2
6
2020
entrez:
8
2
2020
Statut:
ppublish
Résumé
The neuromuscular system of parasitic nematodes has proven to be an efficient pharmacological target for antihelmintics. Some of the most frequently used antiparasitic drugs are agonists or antagonists of nicotinic acetylcholine receptors (nAChRs). The antinematodal mechanism of action of carvacrol involves the inhibition of parasite muscle contraction. We have examined the interaction of carvacrol with antinematodal drugs that are agonists of different subtypes of nAChRs and monepantel, which is a non-competitive antagonist of this receptor in A. suum. Additionally, we investigated the effect of carvacrol on the muscle type of nAChRs in the mammalian host. As orthosteric agonists of nAChR, pyrantel, morantel and befinijum lead to dose-dependent contractions of the neuromuscular preparation of Ascaris suum. Carvacrol 100 μM decreased the E
Identifiants
pubmed: 32032866
pii: S0304-4017(20)30011-X
doi: 10.1016/j.vetpar.2020.109031
pii:
doi:
Substances chimiques
Antinematodal Agents
0
Cymenes
0
Nicotinic Agonists
0
Nicotinic Antagonists
0
Aminoacetonitrile
3739OQ10IJ
monepantel
82MA79VJ33
carvacrol
9B1J4V995Q
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109031Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors have declared that no competing interests exist.